Abstract
The antioxidant enzyme paraoxonase-1 (PON1) may limit oxidative stress in the development of cardiovascular diseases (CVD) and obstructive sleep apnea (OSA). The aim of the study was to determine PON1 gene L55M polymorphism in OSA-positive and OSA-negative subjects, along with paraoxonase activity of the enzyme (PON1-act). Caucasians aged 25–75, with BMI 19.0–53.0 kg/m2 and no acute or severe chronic disorder underwent polysomnography, and OSA-negative (n = 44) and OSA-positive (n = 57) groups were established. The following parameters were assessed: arterial blood pressure and serum glucose, lipids, C–reactive protein, and homocysteine. Genomic DNA was extracted and amplified, and automatic sequencing was used to confirm the LL, LM, MM genotypes. PON1–act was measured spectrophotometrically using paraoxon as a substrate. We found that frequency of polymorphisms differed significantly between the OSA–negative and OSA–positive patients (p < 0.05). Increased PON1–act was observed in the LL–genotype versus the LM + MM–genotype in the study population (p < 0.05). PON1–act was higher in the OSA–negative compared with OSA–positive patients (p < 0.001); in general and in the subgroups presenting the LL or LM genotype. In addition, there was an inverse relationship between PON1–act and LDL–cholesterol in the entire study population. The OSA–positive group presented an inverse relationship between PON1–act and fasting glucose. We conclude that patients could benefit from the LL genotype related with higher activity of PON1. OSA pathology might decrease the enzyme activity, despite the presence of L allele.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo–Parmo SL, La Du BN (1998) Paraoxonase inhibits high–density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590
Baysal E, Taysi S, Aksoy N, Uyar M, Celenk F, Karatas ZA, Tarakcioglu M, Bilinc H, Mumbuc S, Kanlikama M (2012) Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Eur Rev Med Pharmacol Sci 16:770–774
Campo S, Sardo M, Trimarchi G, Bonaiuto M, Fontana L, Castaldo M, Bonaiuto A, Saitta C, Bitto A, Manduca B, Riggio S, Saitta A (2004) Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians. Exp Gerontol 39:1089–1094
Cofta S, Wysocka E, Piorunek T, Rzymkowska M, Batura–Gabryel H, Torlinski L (2008) Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol 59(Suppl6):183–190
Danzi–Soares NJ, Genta PR, Nerbass FB, Pedrosa RP, Soares FS, César LA, Drager LF, Skomro R, Lorenzi–Filho G (2012) Obstructive sleep apnea is common among patients referred for coronary artery bypass grafting and can be diagnosed by portable monitoring. Coron Artery Dis 23:31–38
Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939
Flekac M, Skrha J, Zidkova K, Lacinova Z, Hilgertova J (2008) Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus. Physiol Res 57:717–726
Gbandjaba NY, Ghalim N, Hassar M, Berrougui H, Labrazi H, Taki H, Saile R, Khalil A (2012) Paraoxonase activity in healthy, diabetic and hemodialysis patients. Clin Biochem 45:470–474
Goswami B, Tayal D, Gupta N, Mallika V (2009) Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 410:1–12
Gross ER, Ladisa JFJR, Weihrauch D, Olson LE, Kress TT, Hettrick DA, Pagelps WDC, Kersten JR (2003) Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Phys 284:H1552–H1559
Gupta N, Gill K, Singh S (2009) Paraoxonases: structure, gene polymorphism and role in coronary artery disease. Indian J Med Res 130:361–368
Haj Mouhamed D, Ezzaher A, Mechri A, Neffati F, Omezzine A, Bouslama A, Gaha L, Douki W, Najjar MF (2012) Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Environ Health Prev Med 17:316–321
Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R (2004) Structure and evolution of the serum paraoxonase family detoxifying and anti–atherosclerotic enzymes. Nat Struct Mol Biol 11:412–419
Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase polymorphisms. Nat Genet 3:73–76
Jaouad L, de Guise C, Berrougui H, Cloutier M, Isabelle M, Fultop T, Payette H, Khalil A (2006) Age–related decrease in high–density lipoproteins antioxidant activity is due to an alteration in the PON1’s free sulfhydyl groups. Atherosclerosis 185:191–200
Kallel A, Sediri Y, Sbai MH, Mourali MS, Feki M, Elasmi M, Taieb SH, Sanhaji H, Souheil O, Mechmeche R, Jemaa R, Kaabachi N (2010) The paraoxonase L55M and Q192R gene polymorphisms and myocardial infraction in a Tunisian population. Clin Biochem 43:1461–1463
Kerkeni M, Addad F, Chauffert M, Chuniaud L, Miled A, Trivin F, Maaroufi K (2006) Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem 39:821–825
Kiely JL, McNicholas WT (2000) Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Resir J 16:128–133
Koda Y, Tachida H, Soejima M, Takenaka O, Kimura H (2004) Population differences in DNA sequence variation and linkage disequilibrium at the PON1 gene. Ann Hum Genet 68:110–119
Kotani K, Kimura S, Tsuzaki K, Sakane N, Komada I, Schulze J, Gugliucci A (2008) Reduced paraoxonase 1/arylesterase activity and its post–therapeutic increase in obstructive sleep apnea syndrome: a preliminary study. Clin Chim Acta 395:184–185
Lakshmy R, Ahmad D, Abraham RA, Sharma M, Vemparala K, Das S, Reddy KS, Prabhakaran D (2010) Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infraction & association with oxidized low density lipoprotein. Indian J Med Res 131:522–529
Lavie L, Vishnevsky A, Lavie P (2003) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123–128
Michalak S, Kazmierski R, Hellmann A, Wysocka E, Kocialkowska–Adamczewska D, Wencel–Warot A, Nowinski WL (2011) Serum paraoxonase/arylesterase activity affects outcome in ischemic stroke patients. Cerebrovasc Dis 32:124–132
Morray B, Goldenberg I, Moss AJ, Zareba W, Ryan D, McNitt S, Eberly SW, Glazko G, Mathew J (2007) Polymorphisms in the paraoxonase adn endothelial nitric oxide synthase genes and the risk of early–onset myocardial infraction. Am J Cardiol 99:1100–1105
Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST (2001) Paraoxonase–2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell–mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444–44449
Pasqualini L, Cortese C, Marchesi S, Siepi D, Pirro M, Vaudo G, Liberatoscioli L, Gnasso A, Schillaci G, Mannarino E (2005) Paraoxonase–1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis 183:349–354
Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J (2002) Increased incidence of cardiovascular disease in middle–aged men with obstructive sleep apnea: a 7–year follow–up. Am J Respir Crit Care Med 166:159–165
Sanghera DK, Aston CE, Saha N, Kamboh MI (1998) DNA polymorphisms in two paraoxonase gene (PON1 and PON2) are associted with the risk of coronary heart disease. Am J Hum Genet 62:36–44
Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J (2004) Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta–analysis of 43 studies. Lancet 363:689–695
WHO (1999) Diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Report no. 99. WHO, Geneva, p 2
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034–2041
Zama T, Murata M, Matsubara Y, Kawano K, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y (1997) A 192arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk of coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 17:3565–3569
Conflicts of Interest
The authors declare no conflicts of interests in relation to this work.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Płóciniczak, A. et al. (2018). Paraoxonase 1 Gene L55M Polymorphism and Paraoxonase 1 Activity in Obstructive Sleep Apnea Patients. In: Pokorski, M. (eds) Pulmonary Health and Disorders. Advances in Experimental Medicine and Biology(), vol 1150. Springer, Cham. https://doi.org/10.1007/5584_2018_267
Download citation
DOI: https://doi.org/10.1007/5584_2018_267
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17778-2
Online ISBN: 978-3-030-17779-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)